ABCG2 and cancer: BCRP is also known to be a stem cell marker, whose expression in cancer cells is driven by metabolic and signaling pathways that confer multiple mechanisms of drug resistance, invasiveness (aggressiveness), and self-renewal (64) hence confirming the observed high proliferative ability of the BCRP-overexpressing CASD1 knockout cells.